Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This micro-cap stock is leading the US graphite revolution (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Regencell Bioscience Holdings Ltd RGC

Healthcare Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.


NDAQ:RGC - Post by User

Regencell Bioscience Holdings Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
  • sungrin1309X
Post by sungrin1309on Oct 14, 2022 8:26am
120 Views
Post# 35024304

Live on SSN Network on the effectiveness of TCM in treating

Live on SSN Network on the effectiveness of TCM in treating Live on SSN Network on the effectiveness of TCM in treating COVID19 #RGC

Regencell Bioscience Limited is a Hong Kong-based firm that is pioneering the use of Traditional Chinese Medicine ("TCM") to cure not just ADHD and ASD, but also the Covid-19 virus, which shocked the globe in 2020.

RGC now offers a therapy formula that has been tested on 19 individuals (suspected or confirmed COVID cases). After an average of 5 days of therapy, 12 of 19 patients showed signs of progress in their recovery.

[https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html](https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html)

Separately, while Mr Au, the business's CEO and chairman, was not present for the interview, he has been working behind the scenes to protect his company from recent short seller and trader attacks on the company's shares. Since the company's IPO, Mr Au has purchased nearly $5 million in stock.

"While research is still underway," Mr Au stated, "we are certain that our formula can make a difference in the fight against COVID-19."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities